Compare ยท Lunit
Lunit Pricing and What a Lunit INSIGHT Quote Should Itemize for Radiology Groups
The short answer
Lunit does not publish a price list, so any dollar figure you find online for Lunit INSIGHT is a guess or comes from an unrelated deal. The public record gives you three things instead. The openFDA database lists 6 clearances under Lunit, Inc., 5 for breast imaging detection (QDQ, covering mammography and tomosynthesis) and 1 for chest X-ray triage (QFM). Searches of USAspending.gov on November 1, 2026 found no federal award for Lunit INSIGHT, so no public contract sets a benchmark. Ask for an itemized quote by product, site, reader count and contract term.
Practice administrators and imaging directors searching for Lunit pricing usually find a demo request form. Lunit sells INSIGHT products as separate cleared software for mammography, tomosynthesis and chest X-ray, and it quotes them per customer. There is no public rate card, no self-serve checkout and no federal contract to point at.
That does not leave you empty handed. The FDA record shows exactly which Lunit products are cleared in the United States and when, so you can make the vendor name every product in the proposal instead of accepting a single bundled number. The structure of the quote, which drives the final bill, is the same across the category.
This page does not guess a price. It gives you the verified facts and the line items to demand, then shows where a general reading assistant sits next to a modality specific detection product, because the two are bought for different reasons.
Worklist
Structured report
DraftRun the assistant to draft this report for review.
Decision support. The radiologist reviews and signs every study.
Decision support for qualified clinicians. Radiological.ai does not provide a diagnosis and is not a substitute for professional judgment.
Flag · prioritize · draft · you review and sign
Lunit publishes no price, so the honest answer is the public record: 6 FDA clearances, no federal award to benchmark against, and a line-item list to make the vendor fill in.
Side by side
What is publicly known about Lunit cost
Each row is a sourced fact or an explicit gap. Nothing here is a quote.
| What to check | Lunit | What it means for your quote |
|---|---|---|
| Published price list | None. Pricing is by quote. | Treat every third party estimate as unverified. Ask for the proposal in writing with a line per product. |
| Number of FDA clearances | 6 records under the applicant name Lunit, Inc., from K211678 in November 2021 to K260320 in April 2026. | Six records cover three products and several versions. Ask which version your quote includes and whether upgrades are free. |
| Type of clearance | 5 detection and diagnosis aids for breast imaging (QDQ) across INSIGHT MMG and INSIGHT DBT, 1 chest X-ray triage (QFM). | Most of the US record is breast imaging. A chest X-ray quote and a mammography quote are separate products with separate buyers. |
| Federal purchasing record | USAspending.gov searches for Lunit INSIGHT and Lunit Inc returned no prime award for the AI software. | There is no public award to benchmark against, unlike RapidAI, which has named VA awards. Your leverage is competing quotes. |
| Deployment scope | Quoted per customer, with products, sites, readers and annual study volume as common inputs. | Ask whether adding a site, a mammography unit or a product changes the price and by how much, in writing. |
| Contract shape | Subscription term and renewal terms are negotiated. | Get the renewal uplift cap, the termination rights and the data and image retention terms before you sign. |
| Reading and reporting workflow | Detection marks and scores on the image, plus triage for chest X-ray. | It does not draft the radiology report. That is a separate purchase and a separate budget line. |
Sources are openFDA (collected November 1, 2026) and USAspending.gov award searches run November 1, 2026. A zero result in a federal search does not prove that no agency buys the product through a reseller or another vehicle.
The public clearance record
The Lunit clearances a quote can draw from
Each record is a separate FDA submission for a named product. Ask which of these your proposal actually includes.
| Product | FDA record | What to check |
|---|---|---|
| Lunit INSIGHT MMG (v1.1.10) | K260320, April 23, 2026, QDQ | The newest mammography record. Confirm it is the version in your proposal. |
| Lunit INSIGHT DBT (V1.2) | K253796, March 26, 2026, QDQ | Tomosynthesis detection. Ask whether it is priced separately from the 2D mammography product. |
| Lunit INSIGHT DBT v1.1 | K242652, October 4, 2024, QDQ | An earlier DBT version. Ask what happens to your price when a new version replaces it. |
| Lunit INSIGHT DBT | K231470, November 6, 2023, QDQ | The first tomosynthesis record. Useful to see how the product has been revised. |
| Lunit INSIGHT CXR Triage | K211733, November 10, 2021, QFM | Chest X-ray triage. A different clinical use and buyer than the breast products. |
| Lunit INSIGHT MMG | K211678, November 17, 2021, QDQ | The original mammography record. Check which version your site would actually run. |
Source is openFDA, collected November 1, 2026. The applicant name appears as Lunit, Inc. A clearance belongs to the named device and its intended use, so match each product to the indication you plan to use.
Side by side
Radiological.ai vs Lunit, honestly
A fair look at what each does well. Both are capable tools. Here is where they differ.
| What matters | Radiological.ai | Lunit |
|---|---|---|
| What you are buying | A reading assistant that flags suspected findings, prioritizes the worklist and drafts the structured report across X-ray and CT | Modality specific detection software for mammography and tomosynthesis, plus chest X-ray triage |
| Who feels the benefit | The reading radiologist, in report turnaround and worklist order | The breast imaging reader, in lesion detection support on screening studies |
| Pricing basis | Practice covers X-ray and CT at $199 per reading radiologist per month billed annually, or $399 month to month | No public price. Quoted per customer with products, sites and volume as inputs |
| Integration | Works alongside your PACS over DICOM and returns results over HL7 or FHIR | Connects to the PACS or mammography viewer and shows marks on the image |
| Review | Decision support. The radiologist reviews, edits and signs every report | Cleared detection software. The radiologist makes the final read |
Comparison reflects general, publicly understood positioning. Capabilities change, so check each product for the latest.
If you are choosing between detection vendors, see how the field splits in the best AI radiology software compared, and the triage platforms side by side in Aidoc vs Viz.ai vs RapidAI. The same question for a triage platform is answered in Aidoc pricing.
Contracts in this category share the same traps. Our guide to radiology AI platform pricing shows what public award records reveal about per module billing, and radiology AI vendor evaluation questions lists what to ask before the demo. Reporting side costs sit on the Radiological.ai pricing page.
Why groups pick Radiological.ai
One assistant across the whole read
Make the quote itemize every product
A single number hides what you are paying for. Ask for a line per cleared product, with the FDA record it relies on, so you can see what is core and what is optional. If a product you do not plan to use is bundled, ask what the price is without it.
Price the volume you actually read
Screening practices read large volumes and per study economics change with them. Ask for the price at your current annual volume and at the volume you expect in three years, and get the per site and per unit add-on cost written down.
Cap the renewal
Subscription AI is where renewal uplifts hide. Ask for a written cap on annual increases, the notice period for non-renewal and what happens to your configuration and history if you leave.
Do not confuse detection with reporting
Detection software marks findings on the image. It does not write the report. If report turnaround is the bottleneck, a reading assistant solves a different problem and is bought from a different budget, so compare the two on what each one removes from your day.
Good questions
Lunit vs Radiological.ai, answered
More comparisons
See how Radiological.ai compares
Aidoc alternative
One assistant across the whole read, not acute triage alone.
vs Rad AIRad AI alternative
Drafting plus flagging and triage, in one assistant.
vs DeepHealthDeepHealth alternative
Reporting AI without buying it from a competitor.
vs Fluency for ImagingPowerScribe vs Fluency for Imaging
The two reporting platforms most US groups actually shortlist.
vs Annalise.aiAnnalise.ai alternative
Finding flags plus triage and drafting, together.
vs Nuance PowerScribeNuance PowerScribe alternative
More than dictation: flagging, triage and drafting.
vs Qure.aiQure.ai alternative
Flags plus triage and drafting, in one assistant.
vs Viz.aiViz.ai alternative
Beyond acute stroke triage, across the whole read.
vs Nuance DAXNuance DAX alternative
Built for the read, not for the patient conversation.
vs LunitLunit alternative
One assistant across the whole read, not detection on two modalities.
vs GleamerGleamer alternative
One assistant across X-ray, CT and MRI, not a suite of per-exam detectors.
vs PowerScribe OnePowerScribe One vs 360
What actually changes in the cloud move, and the third option.
vs Sirona MedicalSirona Medical alternative
Add the assistant to the PACS you already run, without replacing the stack.
vs New LanternNew Lantern alternative
AI drafting and triage on the PACS you keep, not a new platform.
vs RapidAIRapidAI alternative
Past the stroke pathway, across the whole reading list.
vs Dragon Medical OneDragon Medical One pricing
Microsoft publishes no price. Here are 25 real federal contracts that do.
vs PowerScribePowerScribe pricing
No list price exists. Here are the only verifiable numbers that do.
vs PowerScribePowerScribe templates
What AutoText actually is, how to get yours out, and what survives a migration.
vs RADPAIR and PowerScribeRadPair vs PowerScribe
Three ways to write the report, compared on what each one actually replaces.
vs Aidoc and Viz.aiAidoc vs Viz.ai
Three acute triage platforms, compared on what they were each built to do.
vs vRad (Virtual Radiologic)vRad alternative
vRad publishes no rate card. 357 federal contract awards do.
vs ONRADONRAD alternative
ONRAD publishes no rate card. 80 federal contract awards do.
vs Real RadiologyReal Radiology alternative
Real Radiology publishes no rate card. 41 Army and VA contract awards do.
vs Experity TeleradiologyExperity Teleradiology alternative
The urgent care reading service that started as one Scottsdale radiologist and now sits inside an EMR company.
vs Sectra PACSSectra PACS alternative
The PACS that keeps winning satisfaction surveys, sold as a cloud subscription with no public price.
vs Visage PACSVisage PACS alternative
The fastest-growing enterprise viewer in US radiology, priced per transaction and disclosed deal by deal.
vs Intelerad PACSIntelerad PACS alternative
The teleradiology favorite, now a GE HealthCare business, with a renewal conversation that just changed.
vs Exa PACSExa PACS alternative
Often sold alongside a Konica X-ray room, with a thin public record you should fill in before you sign.
vs GE Centricity PACSGE Centricity PACS alternative
An aging install base, three GE PACS lines under one owner, and a recall record you should read before the renewal.
vs Agfa PACSAgfa PACS alternative
A Best in KLAS platform, a federal record over $300 million, and an IMPAX install base being moved to the cloud.
vs McKesson PACSMcKesson PACS alternative
A Horizon Medical Imaging install base now owned by Optum, a $98 million federal record and a cloud PACS sold per study.
vs Mach7Mach7 alternative
A Vermont-run, ASX-listed enterprise imaging vendor with a new CEO, falling revenue and a seat on the VA teleradiology PACS.
vs iCADiCAD ProFound AI alternative
The first FDA-cleared AI for breast tomosynthesis, now owned by RadNet, the largest operator of US outpatient imaging centers.
vs ScreenPoint TransparaTranspara alternative
Dutch mammography AI sold in the US through Siemens Healthineers and Fujifilm units, with the strongest trial record in the category.
vs Cortechs.ai NeuroQuantNeuroQuant alternative
The longest-cleared brain volumetrics product in the US, bought by imaging centers, neurology groups, the VA and military hospitals.
vs Avicenna.AI CINAAvicenna AI alternative
CT triage for stroke, pulmonary embolism and spine fractures, usually bought inside a scanner or platform vendor's bundle.
vs VIDIStarVIDIStar alternative
A Greenville cardiology PACS bought by Hitachi in 2018, inherited by Fujifilm in 2021 and sold today as Synapse Select.
vs Subtle MedicalSubtle Medical alternative
Two vendor-neutral MRI acceleration products, four scanner makers with their own, and the FDA and federal purchase records behind each.
vs Riverain ClearRead CTClearRead CT alternative
Compare the lung CT CAD clearance record, VA orders and support for the whole read.
vs Nanox AI (formerly Zebra Medical Vision)Nanox AI alternative
Compare calcium scoring, bone health, liver fat and the report workflow.
vs Viz.aiViz.ai pricing
No list price exists. Here is the public record and the quote checklist.
vs AidocAidoc pricing
No list price exists. Here is the public record and the quote checklist.
vs Blackford AI (Blackford Analysis, formerly Bayer Calantic)Blackford AI alternative
Compare ownership, app catalogs, FDA records and contract terms after the Azra AI deal.
From the blog: what the PowerScribe 360 end of life means for radiology groups, how much radiology AI costs, and the full comparison of the best AI radiology software in 2026.
See how Radiological.ai reads alongside your group
One assistant that flags suspected findings, prioritizes the worklist, and drafts the structured report on X-ray, CT and MRI. You review and sign every study.
Decision support for qualified clinicians. Radiological.ai does not provide a diagnosis and is not a substitute for professional medical judgment.